Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

Company Growth (employees)
Type
Public
HQ
Paris, FR
Founded
2004
Size (employees)
106,859 (est)-7%
Sanofi was founded in 2004 and is headquartered in Paris, FR

Key People at Sanofi

Olivier Brandicourt

Olivier Brandicourt

CEO
Olivier Charmeil

Olivier Charmeil

Executive Vice President and General Manager
Jerome Contamine

Jerome Contamine

Executive Vice President & Chief Financial Officer
Peter Guenter

Peter Guenter

Executive Vice President & General Manager
Karen Linehan

Karen Linehan

Executive Vice President, Legal Affairs and General Counsel
David Loew

David Loew

Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan

Philippe Luscan

Executive Vice President, Global Industrial Affairs
Alan Main

Alan Main

Executive Vice President, Consumer Healthcare
Muzammil Mansuri

Muzammil Mansuri

Executive Vice President, Strategy & Business Development
David Meeker

David Meeker

Executive Vice President and General Manager of Sanofi Genzyme
Ameet Nathwani

Ameet Nathwani

Executive Vice President, Medical Affairs
Roberto Pucci

Roberto Pucci

Executive Vice President, Human Resources
Elias Zerhouni

Elias Zerhouni

President, Global Research & Development

Sanofi Office Locations

Sanofi has offices in Paris, Bridgewater, Macquarie Park, Ontario and in 9 other locations
Paris, FR
Ho Chi Minh City, VN
Séoul, KR
Singapore, SG
Moscow, RU
Mexico City, MX
Tokyo, JP
New Delhi, IN
Hong-Kong, HK
Beijing, CN
Ontario, CA
Macquarie Park, AU
Bridgewater, US

Sanofi Metrics

Sanofi Summary

Market capitalization

€104.9 b

Closing share price

€82.7
Sanofi's current market capitalization is €104.9 b.

Sanofi Financials

Sanofi's revenue is €37.1 b in FY, 2015 which is a 9.7% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

€33 b€33.8 b€37.1 b

Revenue growth, %

2.5%9.7%

Cost of goods sold

€10.3 b€10.2 b€10.9 b

Gross profit

€20.7 b€21.5 b€23.6 b

Gross profit Margin, %

62.7%63.6%63.7%

R&D expense

€4.6 b€4.7 b€5.1 b

General and administrative expense

€8 b€8.4 b€9.4 b

Operating expense total

€12.6 b€13.1 b€14.5 b

Depreciation and amortization

€5.1 b€3.3 b€4.3 b

Interest expense

(€609 m)(€598 m)(€559 m)

Interest income

€111 m€192 m€178 m

Income tax expense

€726 m(€1.2 b)(€709 m)

Net Income

€3.9 b€4.5 b€4.4 b

Operating cash flow

€6.4 b€6.3 b€7.2 b

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Ongoing Phase III Programs

11D9E8C5B

Projects in R&D Pipeline

36D32E34C43B

Drugs Approved by FDA

1A

Sanofi Market Value History

Sanofi Revenue Breakdown

Sanofi Online Presence

Sanofi Company Life

You may also be interested in